You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Red Sox Live

2

1

▲  8th Inning 2 outs

Mass. Movers

FDA upholds rejection of Anika treatment

Anika develops hyaluronic acid-based products for tissue repair. The FDA rejected its knee treatment.

Brian Feulner for the Globe/File

Anika develops hyaluronic acid-based products for tissue repair. The FDA rejected its knee treatment.

Continue reading below

Shares of Anika Therapeutics Inc. skidded lower after the Bedford company said that the Food and Drug Administration had upheld its decision against approving Anika’s osteoarthritis treatment, Monovisc. The company said it will schedule a meeting with the FDA and then decide on its next steps. Monovisc is designed to treat pain in patients who suffer from ­osteoarthritis of the knee. It has been on the market in ­Europe since 2008 and was ­approved in Canada in 2009.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.